Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119267692 | 11926769 | 2 | F | 2006 | 20160802 | 20160119 | 20160812 | PER | US-BAYER-2016-004737 | BAYER | 0.00 | E | F | Y | 72.56000 | KG | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119267692 | 11926769 | 1 | PS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | 19537 | 500 | MG | TABLET | BID | ||||||
| 119267692 | 11926769 | 2 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 400 MG, QD | 0 | 400 | MG | FILM-COATED TABLET | QD | |||||||
| 119267692 | 11926769 | 3 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 500 MG, QD | 0 | 500 | MG | QD | ||||||||
| 119267692 | 11926769 | 4 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 119267692 | 11926769 | 5 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 0 | ||||||||||||
| 119267692 | 11926769 | 6 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 250 MG, UNK | 0 | 250 | MG | MODIFIED-RELEASE FILM-COATED TABLET | ||||||||
| 119267692 | 11926769 | 7 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, UNK | 0 | 500 | MG | MODIFIED-RELEASE FILM-COATED TABLET | ||||||||
| 119267692 | 11926769 | 8 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 750 MG, UNK | 0 | 750 | MG | MODIFIED-RELEASE FILM-COATED TABLET | ||||||||
| 119267692 | 11926769 | 9 | C | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | 81 MG, BID | 0 | 81 | MG | BID | ||||||||
| 119267692 | 11926769 | 10 | C | COQ10 | UBIDECARENONE | 1 | 200 MG, QD | 0 | 200 | MG | QD | ||||||||
| 119267692 | 11926769 | 11 | C | IMDUR | ISOSORBIDE MONONITRATE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 119267692 | 11926769 | 12 | C | PROMETHAZINE HYDROCHLORIDE. | PROMETHAZINE HYDROCHLORIDE | 1 | 150 MG, 4IW | 0 | 150 | MG | |||||||||
| 119267692 | 11926769 | 13 | C | RANITIDINE HYDROCHLORIDE. | RANITIDINE HYDROCHLORIDE | 1 | 150 MG, BID | 0 | 150 | MG | BID | ||||||||
| 119267692 | 11926769 | 14 | C | MELOXICAM. | MELOXICAM | 1 | 15 MG, QD | 0 | 15 | MG | QD | ||||||||
| 119267692 | 11926769 | 15 | C | SERTRALINE HYDROCHLORIDE. | SERTRALINE HYDROCHLORIDE | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 119267692 | 11926769 | 16 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 0.05 MG, QD | 0 | .05 | MG | QD | |||||||
| 119267692 | 11926769 | 17 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 10 MG, TID | 0 | 10 | MG | TID | ||||||||
| 119267692 | 11926769 | 18 | C | BISOPROLOL [BISOPROLOL] | 2 | 10 MG-6.25 MG TABLET HALF | 0 | 10 | MG | QD | |||||||||
| 119267692 | 11926769 | 19 | C | TEKTURNA | ALISKIREN HEMIFUMARATE | 1 | 150 MG, QD | 0 | 150 | MG | QD | ||||||||
| 119267692 | 11926769 | 20 | C | EPIPEN | EPINEPHRINE | 1 | 0.3 MG, QD | 0 | .3 | MG | QD | ||||||||
| 119267692 | 11926769 | 21 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 325 MG, QID | 0 | 325 | MG | QID | |||||||
| 119267692 | 11926769 | 22 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | Intravenous (not otherwise specified) | 2.5 MG, 4IW | 0 | 2.5 | MG | ||||||||
| 119267692 | 11926769 | 23 | C | METHIMAZOLE. | METHIMAZOLE | 1 | 05 MG, QD | 0 | 5 | MG | QD | ||||||||
| 119267692 | 11926769 | 24 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Oral | 250 MG, QD | 0 | 250 | MG | QD | |||||||
| 119267692 | 11926769 | 25 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | 500 MG, QD | 0 | 500 | MG | QD | ||||||||
| 119267692 | 11926769 | 26 | C | THEOPHYLLINE | THEOPHYLLINE ANHYDROUS | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 119267692 | 11926769 | 27 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 60 MG, QD | 0 | 60 | MG | QD | ||||||||
| 119267692 | 11926769 | 28 | C | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, TID | 0 | 600 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119267692 | 11926769 | 1 | Diverticulitis |
| 119267692 | 11926769 | 3 | Sinusitis |
| 119267692 | 11926769 | 4 | Diverticulitis |
| 119267692 | 11926769 | 5 | Bronchitis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119267692 | 11926769 | Depression | |
| 119267692 | 11926769 | Hypoaesthesia | |
| 119267692 | 11926769 | Injury | |
| 119267692 | 11926769 | Neuropathy peripheral | |
| 119267692 | 11926769 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |